Hans Kang is a Managing Director at C-Bridge Capital, whose known portfolio counts 5 companies.
Is Hans Kang a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Managing Director at C-Bridge Capital, whose known portfolio counts 5 companies
- I-Mab Biopharma
- Ascletis
- FitSAMO
- Leo Summit
- Yaneng Biotechnology
Investor Profile
Hans Kang is listed against sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Life Science in the database.
Stage-wise, the deals at C-Bridge Capital cluster around Late-Stage rounds.
What the affiliated firm has backed is the closest available signal on whether Hans Kang is worth approaching.
Colleagues at C-Bridge Capital
Frequently asked questions
Who is Hans Kang?
Hans Kang is a private equity investor based in Hong Kong, listed as Managing Director at C-Bridge Capital. The known portfolio of that firm counts 5 companies. That portfolio belongs to the firm, not to Hans Kang personally.
What does Hans Kang invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Life Science. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Hans Kang invest at?
C-Bridge Capital appears in Late-Stage rounds across its known deals, and Hans Kang is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Hans Kang listed at?
Hans Kang is listed as Managing Director at C-Bridge Capital. 12 other people in the database share a firm with Hans Kang.
How do I contact Hans Kang?
An email address, a phone number and a LinkedIn page are on file for Hans Kang. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal